Sleep and the Pharmacotherapy of Alcohol Use Disorder: Unfortunate Bedfellows. A Systematic Review With Meta-Analysis
Background: Sleep disorders are commonly associated with acute and chronic use of alcohol and with abstinence. To date, there are four approved drugs to treat alcohol use disorder (AUD): disulfiram, acamprosate, naltrexone, and nalmefene. These AUD therapies reduce the craving and risk of relapse in...
Main Authors: | Francesca Panin, Alessandra T. Peana |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01164/full |
Similar Items
-
Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions
by: Emily C. Williams, et al.
Published: (2019-02-01) -
Pharmacogenomics of alcohol addiction: Personalizing pharmacologic treatment of alcohol dependence
by: Ragia Georgia, et al.
Published: (2014-01-01) -
Alcohol abuse and related disorders treatment of alcohol dependence
by: Yu. P. Sivolap
Published: (2014-10-01) -
Practical outpatient pharmacotherapy for alcohol use disorder
by: Youngjung Kim, et al.
Published: (2018-02-01) -
Pharmacogenetics of alcohol addiction: current perspectives
by: Zastrozhin MS, et al.
Published: (2019-07-01)